The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of EGFR inhibition in atypical (non-V600E) BRAF-mutated metastatic colorectal cancer.
 
Benny Johnson
No Relationships to Disclose
 
Jonathan M. Loree
Consulting or Advisory Role - Ipsen; Novartis; Taiho Pharmaceutical
 
Van K. Morris
Consulting or Advisory Role - Clinical Genomics
Travel, Accommodations, Expenses - Array BioPharma
 
Arvind Dasari
Consulting or Advisory Role - Abbvie/Stemcentrx; Ipsen; Lexicon; Novartis; Voluntis
Research Funding - eFFECTOR Therapeutics; Eisai; Novartis
 
Shubham Pant
No Relationships to Disclose
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - Bayer (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amal Therapeutics; Biocartis; EMD Serono; Genentech; Holy Stone Healthcare; Holy Stone Healthcare; Karyopharm Therapeutics; Merck; Navire; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)